Document is current
Any future updates will be listed below
-
Authors
Geagea, Mabelissa
Kozaily, Elie https://orcid.org/0000-0002-6719-0422
Buchanan, Cole
Litwin, Sheldon
Tedford, Ryan J.
- License Information
-
More Information
Article History
Received: 30 October 2025
Revised: 29 December 2025
Accepted: 14 February 2026
First Online: 23 March 2026
Declarations
:
: Dr. Geagea and Dr Kozaily report no disclosures. Dr. Buchanan reports travel support from Abbott and CVRx. Dr. Litwin reports consulting relationships with Corvia, Axon, Novo Nordisk, Eli Lilly, Alleviant and Intershunt.Dr. Tedford is Deputy Editor for the Journal of Heart and Lung Transplantation. He reports general disclosures to include consulting relationships with and receiving honorarium/consulting fees from Abbott, Acorai, Adona, Aria CV Inc., Acceleron, Boston Scientific, CVRx, Endotronix, Edwards LifeSciences, Fauna Bio, Gradient, Imbria, Medtronic, Merck, Morphic Therapeutics, Pulmovant, Restore Medical, Tempus AI, 35Pharma, and United Therapeutics. Dr. Tedford serves on steering committees for Abbott, Edwards, Endotronix, Gradient, Merck, Restore Medical, and Tempus AI as well as a research advisory board for Abiomed.
